SCHEMBL567948

SCHEMBL567948

CCC1CNCCCCN1S(=O)(=O)c1ccc2cnccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.49
PKM P14618 1/20 0.49
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42
APH1B Q8WW43 1/20 0.42
NCSTN Q92542 1/20 0.42
APH1A Q96BI3 1/20 0.42
PSENEN Q9NZ42 1/20 0.42
ROCK1 Q13464 4/20 0.42
JAK2 O60674 3/20 0.42
ROCK2 O75116 3/20 0.42
JAK3 P52333 1/20 0.41
TSHR P16473 3/20 0.41
TP53 P04637 2/20 0.41
CASP3 P42574 2/20 0.40
CASP7 P55210 2/20 0.40
NAMPT P43490 1/20 0.40
HPGD P15428 1/20 0.39
PRKD3 O94806 1/20 0.39
PRKCG P05129 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL567947 1.00 POLB (0.49) POLBPKMPSEN1PSEN2APH1B
Hydrochloric Acid SCHEMBL567662 0.99 POLB (0.48) POLBPKMPSEN1PSEN2APH1B
Hydrochloric Acid SCHEMBL567663 0.99 POLB (0.48) POLBPKMPSEN1PSEN2APH1B
SCHEMBL567301 0.97 POLB (0.48) POLBPKMPSEN1PSEN2APH1B
SCHEMBL567302 0.97 POLB (0.48) POLBPKMPSEN1PSEN2APH1B
Hydrochloric Acid SCHEMBL568051 0.96 POLB (0.47) POLBPKMPSEN1PSEN2APH1B
Hydrochloric Acid SCHEMBL568052 0.96 POLB (0.47) POLBPKMPSEN1PSEN2APH1B
SCHEMBL567071 0.90 ROCK1 (0.42) POLBPKMROCK1JAK2ROCK2
SCHEMBL567072 0.90 ROCK1 (0.42) POLBPKMROCK1JAK2ROCK2
Hydrochloric Acid SCHEMBL567136 0.89 ROCK1 (0.41) POLBPKMROCK1JAK2ROCK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2444395-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVE WESTERN THERAPEUTICS INST INC D (JP) 2016-01-06 EP claimed
US-8951997-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2015-02-10 US claimed
EP-2444395-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. Western Therapeutics Institute, Inc. (JP) 2012-04-25 EP claimed
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) 2012-02-09 US claimed
EP-2444395-B1 SUBSTITUTED ISOQUINOLINE DERIVATIVE WESTERN THERAPEUTICS INST INC D (JP) 2016-01-06 EP disclosed
US-8951997-B2 Substituted isoquinoline derivative D. WESTERN THERAPEUTICS INSTITUTE, INC. (JP) 2015-02-10 US disclosed
EP-2444395-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. Western Therapeutics Institute, Inc. (JP) 2012-04-25 EP disclosed
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE D. WESTERN THERAPEUTICS INSTITUTE, INC (JP) 2012-02-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120035159-A1 SUBSTITUTED ISOQUINOLINE DERIVATIVE SULT1A1, SULT1E1, SULT2A1 POLB 3646/4885PKM 3496/4885PSEN1 4661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.